Azitra News
News
0
Ticker
AZTR
ISIN
US05479L3024
Azitra Eulerpool News
Azitra Stock News
Azitra is being monitored by journalists and investors worldwide. We gather the latest Azitra news here.
- March 20·ChartMill
- March 20·ChartMill
- March 20·ChartMill
- March 20·ChartMill
- March 20·ChartMill
- March 20·Benzinga
- March 20·Benzinga
- March 20·Benzinga
- March 20·Benzinga
- February 4·Benzinga
- December 17·Yahoo
- November 24·Benzinga
- November 12·Benzinga
- November 7·Yahoo
- October 20·Benzinga
- August 27·Yahoo
- August 27·Benzinga
- August 25·Yahoo
- August 11·Yahoo
- August 11·Benzinga
Azitra Stock Press Releases
Azitra regularly publishes news on the company's website that are relevant for investors.
Azitra News 2026
This page contains all current news, analysis and press releases for Azitra stock (AZTR, ISIN: US05479L3024). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Azitra.
Azitra Stock
Azitra Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees.